| SCHEDULE OF DISAGGREGATION OF REVENUE |
SCHEDULE OF DISAGGREGATION OF REVENUE
| | |
2026 | | |
2025 | |
| | |
For the Years Ended March 31, | |
| | |
2026 | | |
2025 | |
| Direct sales to Wholesalers | |
$ | 65,273,763 | | |
$ | 48,008,986 | |
| Indirect sales to Wholesalers | |
| 82,536,359 | | |
| 33,977,093 | |
| Total Manufacturing Fees | |
$ | 147,810,122 | | |
$ | 81,986,079 | |
| | |
2026 | | |
2025 | |
| | |
For the Years Ended March 31, | |
| | |
2026 | | |
2025 | |
| Scheduled Products – Manufacturing Fees | |
$ | 141,465,975 | | |
$ | 74,756,506 | |
| Scheduled Products – Licensing Fees | |
| 465,511 | | |
| 248,789 | |
| Unscheduled Products – Manufacturing Fees | |
| 6,344,147 | | |
| 7,229,573 | |
| Unscheduled Products – Licensing Fees | |
| 594,486 | | |
| 1,809,061 | |
| Total Revenue | |
$ | 148,870,119 | | |
$ | 84,043,929 | |
|
| SCHEDULE OF EARNINGS (LOSS) PER SHARE APPLICABLE TO COMMON SHAREHOLDERS |
The
following is the computation of earnings per share applicable to common shareholders for the periods indicated:
SCHEDULE OF EARNINGS (LOSS) PER SHARE APPLICABLE TO COMMON SHAREHOLDERS
| | |
2026 | | |
2025 | |
| | |
For the Years Ended March 31, | |
| | |
2026 | | |
2025 | |
| Numerator | |
| | | |
| | |
| Net income (loss) - basic | |
$ | 44,872,686 | | |
$ | (4,314,659 | ) |
| Effect of dilutive instrument on net income - warrants | |
| (7,855,607 | ) | |
| — | |
| Net income (loss) - diluted | |
$ | 37,017,079 | | |
$ | (4,314,659 | ) |
| | |
| | | |
| | |
| Denominator | |
| | | |
| | |
| Weighted average shares of Common Stock outstanding - basic | |
| 1,072,837,856 | | |
| 1,068,290,368 | |
| Dilutive effect of stock options and convertible securities | |
| 65,530,379 | | |
| — | |
| Weighted average shares of Common Stock outstanding - diluted | |
| 1,138,368,235 | | |
| 1,068,290,368 | |
| | |
| | | |
| | |
| Net income (loss) per share | |
| | | |
| | |
| Basic | |
$ | 0.04 | | |
$ | (0.00 | ) |
| Diluted | |
$ | 0.03 | | |
$ | (0.00 | ) |
|